136 related articles for article (PubMed ID: 1868115)
1. A novel bifunctional metabolizable linker for the conjugation of antibodies with radionuclides.
Arano Y; Matsushima H; Tagawa M; Koizumi M; Endo K; Konishi J; Yokoyama A
Bioconjug Chem; 1991; 2(2):71-6. PubMed ID: 1868115
[TBL] [Abstract][Full Text] [Related]
2. A newly designed radioimmunoconjugate releasing a hippurate-like radiometal chelate for enhanced target/non-target radioactivity.
Arano Y; Matsushima H; Tagawa M; Inoue T; Koizumi M; Hosono M; Sakahara H; Endo K; Konishi J; Yokoyama A
Nucl Med Biol; 1994 Jan; 21(1):63-9. PubMed ID: 9234265
[TBL] [Abstract][Full Text] [Related]
3. Discriminated release of a hippurate-like radiometal chelate in nontarget tissues for target-selective radioactivity localization using pH-dependent dissociation of reduced antibody.
Arano Y; Inoue T; Mukai T; Wakisaka K; Sakahara H; Konishi J; Yokoyama A
J Nucl Med; 1994 Feb; 35(2):326-33. PubMed ID: 8295006
[TBL] [Abstract][Full Text] [Related]
4. Preparation of 67Ga-labeled antibodies using deferoxamine as a bifunctional chelate. An improved method.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Ohmomo Y; Arano Y; Yokoyama A
J Immunol Methods; 1987 Nov; 104(1-2):93-102. PubMed ID: 3316401
[TBL] [Abstract][Full Text] [Related]
5. Stability of a metabolizable ester bond in radioimmunoconjugates.
Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
[TBL] [Abstract][Full Text] [Related]
6. Assessment of radiochemical design of antibodies using an ester bond as the metabolizable linkage: evaluation of maleimidoethyl 3-(tri-n-butylstannyl)hippurate as a radioiodination reagent of antibodies for diagnostic and therapeutic applications.
Arano Y; Wakisaka K; Ohmono Y; Uezono T; Akizawa H; Nakayama M; Sakahara H; Tanaka C; Konishi J; Yokoyama A
Bioconjug Chem; 1996; 7(6):628-37. PubMed ID: 8950481
[TBL] [Abstract][Full Text] [Related]
7. Development of Ga-67 labeled DFO-DAS-fibrinogen conjugate as a thrombus imaging agent.
Yamaoka S
Radiat Med; 1987; 5(5):151-3. PubMed ID: 3438481
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of labeling efficiency, biological activity and biodistribution among 125I-, 67Ga-DTPA-and 67Ga-DFO-lectins.
Kojima S; Jay M
Eur J Nucl Med; 1987; 13(7):366-70. PubMed ID: 3428286
[TBL] [Abstract][Full Text] [Related]
9. Labeling of monoclonal antibodies with a 67Ga-phenolic aminocarboxylic acid chelate. Part I. Chemistry and labeling technique.
Schuhmacher J; Matys R; Hauser H; Maier-Borst W; Matzku S
Eur J Nucl Med; 1986; 12(8):397-404. PubMed ID: 3792374
[TBL] [Abstract][Full Text] [Related]
10. Elimination of free radionuclide by a chelating agent improves tumor-to-nontumor ratios following radioimmunotargeting with antibody labeled with 67Ga.
Ryser JE; Rose K; Jones R; Pelegrin A; Donath A; Egeli R; Smith A; Offord RE
Nucl Med Biol; 1998 Apr; 25(3):261-5. PubMed ID: 9620632
[TBL] [Abstract][Full Text] [Related]
11. An approach for immunoradiometric assay with metallic radionuclides: gallium-67-deferoxamine-dialdehyde starch-IgG.
Furukawa T; Fujibayashi Y; Fukunaga M; Saga T; Endo K; Yokoyama A
J Nucl Med; 1991 May; 32(5):825-9. PubMed ID: 2022990
[TBL] [Abstract][Full Text] [Related]
12. Succinylated polylysine as a possible link between an antibody molecule and deferoxamine.
Slinkin MA; Klibanov AL; Khaw BA; Torchilin VP
Bioconjug Chem; 1990; 1(4):291-5. PubMed ID: 2096922
[TBL] [Abstract][Full Text] [Related]
13. Preparation of 67Ga-labelled human IgG and its Fab fragments using desferoxamine as chelating agent.
Motta-Hennessy C; Eccles SA; Dean C; Coghlan G
Eur J Nucl Med; 1985; 11(6-7):240-5. PubMed ID: 4076230
[TBL] [Abstract][Full Text] [Related]
14. Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies.
Smith-Jones PM; Stolz B; Bruns C; Albert R; Reist HW; Fridrich R; Mäcke HR
J Nucl Med; 1994 Feb; 35(2):317-25. PubMed ID: 8295005
[TBL] [Abstract][Full Text] [Related]
15. Deferoxamine as a chelator for 67Ga in the preparation of antibody conjugates.
Govindan SV; Michel RB; Griffiths GL; Goldenberg DM; Mattes MJ
Nucl Med Biol; 2005 Jul; 32(5):513-9. PubMed ID: 15982582
[TBL] [Abstract][Full Text] [Related]
16. 67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Koizumi M; Endo K; Kunimatsu M; Sakahara H; Nakashima T; Kawamura Y; Watanabe Y; Saga T; Konishi J; Yamamuro T
Cancer Res; 1988 Mar; 48(5):1189-94. PubMed ID: 3422590
[TBL] [Abstract][Full Text] [Related]
17. Labeling of sarcoma associated monoclonal antibody with 111In, 67Ga and 125I.
Lavie E; Boazi M; Weininger J; Bitton M; Yosilevski G; Front D; Hirshaut Y; Robinson E; Bartal AH
Radiother Oncol; 1987 Feb; 8(2):129-35. PubMed ID: 3562892
[TBL] [Abstract][Full Text] [Related]
18. The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions.
Caraco C; Aloj L; Eckelman WC
Appl Radiat Isot; 1998 Dec; 49(12):1477-9. PubMed ID: 9745687
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine mesylate enhancement of 67Ga tumor-to-blood ratios and tumor imaging.
Koizumi K; Tonami N; Hisada K
Eur J Nucl Med; 1982; 7(5):229-33. PubMed ID: 6954069
[TBL] [Abstract][Full Text] [Related]
20. Enhanced kidney clearance with an ester-linked 99mTc-radiolabeled antibody Fab'-chelator conjugate.
Weber RW; Boutin RH; Nedelman MA; Lister-James J; Dean RT
Bioconjug Chem; 1990; 1(6):431-7. PubMed ID: 2099189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
